About Ark Biosciences
Ark Biosciences is a company based in Shanghai (China) founded in 2014. Ark Biosciences operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Ark Biosciences Private Limited
- Date of Incorporation 19 Jul, 2006
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$3.31 M (USD)137.12as on Mar 31, 2020
-
Net Profit
$615.91 K (USD)444.91as on Mar 31, 2020
-
EBITDA
$609.31 K (USD)5800.07as on Mar 31, 2020
-
Latest Funding Round
Not available
-
Investors
TPG
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ark Biosciences
Investors in Ark Biosciences
Ark Biosciences has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include TPG, Qiming Venture Partners and Visum Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mid-market companies are targeted for investment by Loayal Valley Capital.
|
Locked | Locked | Locked | |
|
Venture capital investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
Private equity & venture capital firm
|
Locked | Locked | Locked |
Investor details for Ark Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ark Biosciences
Investment portfolio details for Ark Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ark Biosciences
Detailed financials for Ark Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ark Biosciences Comparisons
Peer comparison for Ark Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ark Biosciences
Ark Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Developer of biologics to treat hepatitis B infection
|
|
| Locked | Locked | Locked |
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
Detailed competitors of Ark Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ark Biosciences
Complete news archive for Ark Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ark Biosciences
Ark Biosciences was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Ark Biosciences is headquartered in Shanghai, China.
Annual revenue of Ark Biosciences is $3.31M as on Mar 31, 2020.
Ark Biosciences was founded in 2014 in Shanghai, China, as a clinical-stage biopharmaceutical company. Small molecule therapeutics targeting respiratory viral infections and viral hepatitis are developed by the firm. The lead candidate, AK0529, an oral inhibitor of RSV replication, has completed phase 1 trials and is advancing to phase 2. AK-612 for influenza remains in preclinical development, while two additional candidates address hepatitis B virus infections.
Ark Biosciences's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
Ark Biosciences has 17 investors. Key investors include TPG, Qiming Venture Partners, Visum Pharma, Loayal Valley Capital, and Longda Food Group.